Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.
about
Surgery for small asymptomatic abdominal aortic aneurysmsPharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysmPharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysmMast Cell: A Multi-Functional Master CellThe Abdominal Aortic Aneurysm and Intraluminal Thrombus: Current Concepts of Development and TreatmentUnderstanding the pathogenesis of abdominal aortic aneurysmsMedical treatment of aortic aneurysms in Marfan syndrome and other heritable conditionsPharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm.New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3)The role of the renin-angiotensin system in aortic aneurysmal diseases.Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysmsThe Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocolRecent advances in molecular mechanisms of abdominal aortic aneurysm formation.Medical management of small abdominal aortic aneurysmsMeta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms.Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysmsACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysmNovel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans.Genes and abdominal aortic aneurysm.Complex pathologies of angiotensin II-induced abdominal aortic aneurysmsProlonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm.Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening StudyTElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial.Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association.An underused opportunity to introduce ACE inhibitors and influence prognosis: observational study of patients undergoing aortic surgery.Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases.Non-operative or medical management of abdominal aortic aneurysm.The most wanted trials for abdominal aortic aneurysm treatment.ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.Adding an endovascular aortic surgery program to a rural regional medical centreThoracoabdominal aneurysm disease.Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture.Angiotensin-converting enzyme-induced activation of local angiotensin signaling is required for ascending aortic aneurysms in fibulin-4-deficient mice.Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts.Pharmacological treatment of abdominal aortic aneurysm.An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK).Basic science review. Vascular distensibility as a predictive tool in the management of small asymptomatic abdominal aortic aneurysms.Pharmacological therapy for patients with abdominal aortic aneurysm.The management of abdominal aortic aneurysms.
P2860
Q24188191-819EAC6F-7F67-4D67-AD17-57A4E9DC7C5FQ24200504-95597C40-DCB6-44AA-84D1-CCDF5BD919A8Q24201062-C141F940-CC18-477A-951D-A5118845CE05Q26771463-44A01B7E-3392-4933-94D6-9AB452F28F79Q26776131-0877630A-4882-43DA-8BB8-8C47A833E9A9Q26797277-A21037BB-F935-41CC-B079-F34B9A477652Q26823672-4B114B3E-2375-4D72-8151-A9D33F2D39D8Q30239058-EDC6264A-AE31-4075-A908-F4BEB40C7F59Q30393291-EEFACAF5-28DF-4E23-A2CC-71C1AFEBD2C6Q33757332-20EDF517-2482-4D1E-8A45-832F01193269Q33905481-0A306162-C7D0-4410-856B-E1959E554C07Q33939428-9F9E83F5-357C-4BBF-ACF9-4A8E8B404AFAQ34081328-1C05D6E8-FEAC-4DE7-9566-45191C88CFB0Q34103746-A691B6D1-D191-4944-8023-81C09E4118F2Q34184136-0DFCCFF8-9428-4F2B-90EA-9EF2359DEDD4Q34506416-7E6FC9EE-45B3-4981-BDE5-7C7269CBA9BCQ34606642-DDE6195B-C4EA-49E2-AAD6-BA943751CDD3Q34634364-AF73B73D-F9D3-4C86-A193-FBDC8D528853Q34682737-101B5D92-F660-49EB-B706-3A117EDBB41CQ34683905-FCAA2322-76F7-4BC9-8D4A-EC5C23BB532FQ35148843-836BBDB2-8417-48C1-9E30-9A079FD7AF1CQ35167994-6C97E933-8C36-4591-ABC4-C91DD055356FQ35738463-F5C8E109-B240-46DB-A195-AB0AD9EAF5C2Q35786928-95E6624B-4DAC-4C01-B43C-B6283166FBA9Q36830867-2ABB2650-691B-4D4A-86DB-65A678EE1E27Q36971829-B90B3913-02F4-4EAC-AFB4-1028BD46B197Q37086076-8F9A34DA-CDAD-4098-A2F9-ACFB1F98BB14Q37198766-E51A621F-44DC-4B9B-8F1F-8068D7E7F807Q37198801-153AF1B3-1960-458C-AF40-873458A24EEBQ37200287-2C5C8D4C-B37C-4279-A8E7-F7845C604BDCQ37209844-2895BDE6-E955-4A0D-B955-FC06358FCF18Q37340033-5ACCCEA4-8DBB-4035-AEBF-84C2861DAD78Q37394705-A0D05C0D-5B4C-4ACD-A339-16FC12BFE8CAQ37402767-A9301D66-57B7-4405-82C4-D0A96F5F40B5Q37415982-FDD329EE-A68C-4F0F-B977-D5C10A1DC0F4Q37489199-4A858221-6870-485A-AD39-98984249C3B0Q37529894-C7160A8A-D3C4-471F-B99E-86426764D431Q37531492-4C9FF215-CB83-4C16-B7E4-04599B99E610Q37578569-7D8C0556-0564-4EC5-80A0-91FE05401855Q37646013-8207ED21-76F4-41CB-ACE0-8C007003121B
P2860
Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Angiotensin-converting enzyme ...... tion-based case-control study.
@ast
Angiotensin-converting enzyme ...... tion-based case-control study.
@en
Angiotensin-converting enzyme ...... tion-based case-control study.
@nl
type
label
Angiotensin-converting enzyme ...... tion-based case-control study.
@ast
Angiotensin-converting enzyme ...... tion-based case-control study.
@en
Angiotensin-converting enzyme ...... tion-based case-control study.
@nl
prefLabel
Angiotensin-converting enzyme ...... tion-based case-control study.
@ast
Angiotensin-converting enzyme ...... tion-based case-control study.
@en
Angiotensin-converting enzyme ...... tion-based case-control study.
@nl
P2093
P1433
P1476
Angiotensin-converting enzyme ...... tion-based case-control study.
@en
P2093
Daniel G Hackam
Deva Thiruchelvam
Donald A Redelmeier
P304
P356
10.1016/S0140-6736(06)69250-7
P407
P577
2006-08-01T00:00:00Z